Stifel Downgrades Silk Road Medical to Hold, Raises Price Target to $27.5
Stifel Downgrades Silk Road Medical to Hold, Raises Price Target to $27.5
Stifel將絲路醫療股票評級爲持有，價格目標上調至27.5美元。
Stifel analyst Rick Wise downgrades Silk Road Medical (NASDAQ:SILK) from Buy to Hold and raises the price target from $23 to $27.5.
Stifel的分析師Rick Wise將silk road medical (納斯達克:SILK)的評級從買入調降至持有，並將目標股價從$23上調至$27.5。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。